InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,184.40
(
0.27%
)
Post# of 252186
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

10nisman

Send PM Follow Ignore
Followers 24
Posts 2529
Boards Moderated 0
Alias Born 10/26/2003

10nisman

Re: drbio45 post# 1284

Thursday, 02/26/2004 10:31:59 PM

Thursday, February 26, 2004 10:31:59 PM

Post# of 252186
From Briefing.com:
2:52PM EYET also finding bid following Avastin approval news 35.00 +2.63...


EYET's Macugen is a Anti-VEGF like Avastin. I hope EYET goes to $50/sh (non-shareholder of EYET)as one would think GENR's PPS would be bid up as well.





Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up